XOMA Royalty (XOMA) EBIT Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) EBIT Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
XOMA Royalty |
5.49 Mn |
-60.59 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
40.48% |
| Dec 31, 2025 |
-16.06% |
| Sep 30, 2025 |
13.13% |
| Jun 30, 2025 |
28.18% |
| Mar 31, 2025 |
25.03% |
| Dec 31, 2024 |
-12.63% |
| Sep 30, 2024 |
-49.27% |
| Jun 30, 2024 |
-16.43% |
| Mar 31, 2024 |
-41.23% |
| Dec 31, 2023 |
-42.25% |
| Sep 30, 2023 |
-1.75% |
| Jun 30, 2023 |
-14.77% |
| Mar 31, 2023 |
-14.64% |
| Dec 31, 2022 |
-25.31% |
| Sep 30, 2022 |
-16.57% |
| Jun 30, 2022 |
-41.32% |
| Mar 31, 2022 |
28.33% |
| Dec 31, 2021 |
30.18% |
| Sep 30, 2021 |
22.66% |
| Jun 30, 2021 |
29.84% |
